Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementPRNewsWire • 04/16/24
Atossa Therapeutics announces breast cancer trial evaluating lead asset in combination with Eli Lilly drugProactive Investors • 04/15/24
Novo Nordisk and Eli Lilly weight loss drugs may not be a silver bullet, but they have huge potential, says leading US bankProactive Investors • 04/15/24
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughtsCNBC • 04/12/24
Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts sayMarket Watch • 04/12/24
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024InvestorPlace • 04/11/24
Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next MilestoneInvestorPlace • 04/11/24
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 04/10/24
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?Market Watch • 04/10/24
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its BoardAccesswire • 04/10/24
This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug MarketThe Motley Fool • 04/08/24
Wegovy's heart benefits are not just linked with weight loss, new study suggestsMarket Watch • 04/06/24
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the StockThe Motley Fool • 04/06/24
Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?Investors Business Daily • 04/05/24